Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.
This article continues a series of reports on research developments related to the field of heart failure. Reports of presentations made at the Hot Line sessions of the European Society of Cardiology XXIV Congress held in Berlin, Germany, between 31 August and 4 September 2002 are included. Summaries of the results of the following trials are presented: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.
Coletta
A P
AP
Department of Academic Cardiology, University of Hull, Castle Hull Hospital, Kingston-upon-Hull HU15 5JQ, Cottingham, UK. a.p.coletta@hull.ac.uk
Louis
A A
AA
Clark
A L
AL
Nikitin
N
N
Cleland
J G F
JG
D002309:Cardiology; D002986:Clinical Trials as Topic / Q000639:trends*; D005060:Europe; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D012955:Societies, Medical; D018487:Ventricular Dysfunction, Left / Q000628:therapy